【摘 要】
：
Anomalous origin of the right pulmonary artery (AORPA) from the aorta is an uncommon congenital anomaly with survival into adulthood being extremely rare.
【机 构】
：
University of the Free State South Africa
【出 处】
：
BIT`s 4th Annual International Congress of Cardiology-2012(2
论文部分内容阅读
Anomalous origin of the right pulmonary artery (AORPA) from the aorta is an uncommon congenital anomaly with survival into adulthood being extremely rare.
其他文献
Calcific aortic stenosis is now the main cause of aortic stenosis in the majority of patients, due to declining incidence of rheumatic fever.Risk factors such as hyperlipidemia play an important role
Occlusive lesions of prevertebral subclavian artery (PVSA) are rare and often asymptomatic when isolated.Endovascular treatment appeared in the 80s and was an interesting alternative to conventional t
Calcific degenerative aortic valve disease is the most common cause of age-related acquired valve disease.Currently, the only therapeutic options are surgical or percutaneous valve replacement.Attempt
Early on cardiology as a medical specialty was limited mainly to internists but when Dr Robert Gross ligated a PDA in 1938 pediatric cardiology developed.
Mustard or Senning surgeries were the treatment of choice for D-transposition of the great arteries for many years.Since the early and mid-80s, the arterial switch surgery has become the preferred sur
Introduction: Increased fetal nuchal translucency (NT) is known to be associated with chromosomal abnormalities (mostly 21-trisomy), major cardiac defects and other structural defects as well as a wid
Congenital Heart Disease (CHD) affects about 7 to 9 of every 1,000 live births.It is the most common cause of death in the first year of life, accounting for 3% of all infants deaths.
Peri-operative brain injury is common in young infants undergoing cardiac surgery.Seizures have been reported as a common identifying symptom for brain injury.Amplitude-integrated electroencephalograp
Tachyarrhythmias treatment in small children is still challenging because of the absence of prospective controlled studies to test the efficacy of the multiple potential approaches.
Ventricular assist devices have become accepted therapy for treatment of acute cardiogenic shock, decompensated and end-stage heart failure.Current generation of devices is superior to the first gener